Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

Clinical trial NCT00005061 · COMPLETED

Trial details

NCT number: NCT00005061
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1999-12-01
Primary completion: 2001-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.